9 Meters Biopharma (NMTR) Prices 30M Share Public Offering of Common Stock at $1/sh

9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today the pricing of an underwritten public offering of 30,000,000 shares of its common stock at a price to the public of $1.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 4,500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on April 5, 2021, subject to customary closing conditions.

The gross proceeds to the Company from the public offering, before deducting underwriting discounts and commissions and offering expenses payable by 9 Meters, are expected to be approximately $30 million.

Citigroup and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering. Truist Securities, Inc. is also acting as a joint book-running manager for the offering. BMO Capital Markets is serving as financial advisor to the Company.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• GXO Logistics, Inc. (GXO) Launches Notes Offering
• T-Mobile (TMUS) and EQT Announce JV to Acquire Lumos